Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2025-04-09 00:00:00 ET · period of report 2025-04-07 · accession 0001367644-25-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-09 | 2025-04-07 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $4.44 | -480 | 176.2K | -0.3% | -$2,131 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-07 | F | D | 480 | $4.44 | 176,176 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units |